title: Response to letter to the editor regarding Alqahtani et al. Article on priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?
authors.affiliation: International Center of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA.
authors.forename: Enrique
authors.initials: E
authors.lastname: Seoane-Vazquez
authors.affiliation: School of Public Health and Health Sciences, University of Massachusetts, Amherst, USA.
authors.forename: Rosa
authors.initials: R
authors.lastname: Rodriguez-Monguio
authors.affiliation: International Center of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA.
authors.forename: Saad
authors.initials: S
authors.lastname: Alqahtani
mesh_terms: D017277:Drug Approval; D006801:Humans; D014486:United States Food and Drug Administration